Association of Dietary Niacin Intake with Diabetes in Adults in the United States

Abstract

Objective Previous studies have shown inconsistent associations between niacin supplementation and diabetes, and little is known about the relationship between dietary niacin intake and the risk of diabetes in the general population. Our study aimed to explore the association between dietary niacin intake and the risk of diabetes in the adult population in the United States.

Methods Data from the 2005–2016 National Health and Nutrition Examination Surveys were analyzed. Diabetes was diagnosed according to the American Diabetes Association criteria. Multivariate logistic regression models were used to estimate the association between dietary niacin intake and diabetes. Covariates included age, sex, race, family income, educational level, drinking status, smoking status, marital status, and physical activity.

Results This study included 24494 participants, of which 13.63% had diabetes. In the fully adjusted model, a high niacin intake was significantly associated with a reduced risk of diabetes in a dose-dependent manner. When extreme quintiles of niacin intake were compared, the multivariable-adjusted odds ratio was 0.66 (95% confidence interval: 0.49, 0.88) for diabetes, and per ten-unit increment in dietary niacin intake was associated with a 14% lower risk of diabetes. When niacin intake was less than 15.01 mg/d, a ten-unit increment in niacin intake was associated with a 24% higher risk of diabetes. However, the effect was not statistically significant.

Conclusions Our results suggest that the consumption of adequate amounts of niacin can reduce the risk of diabetes. Furthermore, this protective effect disappeared when the niacin intake was insufficient (less than 15.01 mg/d).

Key words

dietary intake - niacin - diabetes - United States

Publication History

Received: 12 October 2022
Received: 01 February 2023

Accepted: 13 February 2023

Accepted Manuscript online:
17 February 2023

Article published online:
22 May 2023

• References

• 1 Sun H, Saeedi P, Karuranga S. et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022; 183: 109119 DOI: 10.1016/j.diabres.2021.109119.
• 2 Chan JCN, Lim LL, Wareham NJ. et al. The Lancet Commission on diabetes: Using data to transform diabetes care and patient lives. Lancet 2021; 396: 2019-2082 DOI: 10.1016/s0140-6736(20)32374-6.
• 3 Wild S, Roglic G, Green A. et al. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053 DOI: 10.2337/diacare.27.5.1047.
• 4 Risk NCD. Factor Collaboration NCD. Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 2016; 387: 1513-1530 DOI: 10.1016/s0140-6736(16)00618-8.
• 5 Lascar N, Brown J, Pattison H. et al. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol 2018; 6: 69-80 DOI: 10.1016/s2213-8587(17)30186-9.
• 6 Benhalima K, Muls E. Niacin, an old drug with new perspectives for the management of dyslipidaemia. Acta Clin Belg 2010; 65: 23-28 DOI: 10.1179/acb.2010.003.
• 7 Moshfegh AJ, Rhodes DG, Baer DJ. et al. The US Department of Agriculture Automated Multiple-Pass Method reduces bias in the collection of energy intakes. Am J Clin Nutr 2008; 88: 324-332 DOI: 10.1093/ajcn/88.2.324.
• 8 Ganji SH, Kamanna VS, Kashyap ML. Niacin and cholesterol: Role in cardiovascular disease (review). J Nutr Biochem 2003; 14: 298-305 DOI: 10.1016/s0955-2863(02)00284-x.
• 9 McKenney J. New perspectives on the use of niacin in the treatment of lipid disorders. Arch Intern Med 2004; 164: 697-705 DOI: 10.1001/archinte.164.7.697.
• 10 Lee JM, Robson MD, Yu LM. et al. Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: A randomized, placebo-controlled, magnetic resonance imaging study. J Am Coll Cardiol 2009; 54: 1787-1794 DOI: 10.1016/j.jacc.2009.06.036.
• 11 Taylor AJ, Villines TC, Stanek EJ. et al. Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med 2009; 361: 2113-2122 DOI: 10.1056/NEJMoa0907569.
• 12 Tang C, Eshak ES, Shirai K. et al. Associations of dietary intakes of vitamins B1 and B3 with risk of mortality from cardiovascular disease among Japanese men and women: the Japan Collaborative Cohort Study. Br J Nutr 2022; 1-27 DOI: 10.1017/s0007114522001209.
• 13 Yan X, Wang S. The efficacy of niacin supplementation in type 2 diabetes patients: Study protocol of a randomized controlled trial. Medicine (Baltimore) 2021; 100: e22272 DOI: 10.1097/md.0000000000022272.
• 14 Guyton JR, Fazio S, Adewale AJ. et al. Effect of extended-release niacin on new-onset diabetes among hyperlipidemic patients treated with ezetimibe/simvastatin in a randomized controlled trial. Diabetes Care 2012; 35: 857-860 DOI: 10.2337/dc11-1369.
• 15 Landray MJ, Haynes R, Hopewell JC. et al. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med 2014; 371: 203-212 DOI: 10.1056/NEJMoa1300955.
• 16 Sazonov V, Maccubbin D, Sisk CM. et al. Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucose. Int J Clin Pract 2013; 67: 297-302 DOI: 10.1111/ijcp.12089.
• 17 Johnson CL, Paulose-Ram R, Ogden CL. et al. National health and nutrition examination survey: Analytic guidelines, 1999-2010. Vital Health Stat 2 2013; 1-24
• 18 Vandenbroucke JP, von Elm E, Altman DG. et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. Ann Intern Med 2007; 147: W163-W194 DOI: 10.7326/0003-4819-147-8-200710160-00010-w1.
• 19 Raper N, Perloff B, Ingwersen L. et al. An overview of USDA’s dietary intake data system. J Food Compos Anal 2004; 17: 545-555 DOI: 10.1016/j.jfca.2004.02.013.
• 20 American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2020. Diabetes Care 2020; 43: S14-S31 DOI: 10.2337/dc20-S002.
• 21 Ogden CL, Carroll MD, Fakhouri TH. et al. Prevalence of obesity among youths by household income and education level of head of household – United States 2011-2014. MMWR Morb Mortal Wkly Rep 2018; 67: 186-189 DOI: 10.15585/mmwr.mm6706a3.
• 22 Chobanian AV, Bakris GL, Black HR. et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572 DOI: 10.1001/jama.289.19.2560.
• 23 Willett W, Stampfer MJ. Total energy intake: Implications for epidemiologic analyses. Am J Epidemiol 1986; 124: 17-27 DOI: 10.1093/oxfordjournals.aje.a114366.
• 24 Goldie C, Taylor AJ, Nguyen P. et al. Niacin therapy and the risk of new-onset diabetes: A meta-analysis of randomised controlled trials. Heart 2016; 102: 198-203 DOI: 10.1136/heartjnl-2015-308055.
• 25 Xiang D, Zhang Q, Wang YT. Effectiveness of niacin supplementation for patients with type 2 diabetes: A meta-analysis of randomized controlled trials. Medicine (Baltimore) 2020; 99: e21235 DOI: 10.1097/md.0000000000021235.
• 26 Ke P, Jiang H, Dowling R. et al. Relationship between dietary niacin intake and diabetes mellitus in the National Health and Nutrition Examination Survey (NHANES) 2003-2018. Eat Weight Disord 2022; DOI: 10.1007/s40519-021-01347-6.
• 27 Liu H, Wang L, Chen C. et al. Association between dietary niacin intake and migraine among American adults: National Health and Nutrition Examination Survey. Nutrients 2022; 14 DOI: 10.3390/nu14153052.
• 28 Mahalle N, Kulkarni MV, Naik SS. et al. Association of dietary factors with insulin resistance and inflammatory markers in subjects with diabetes mellitus and coronary artery disease in Indian population. J Diabetes Complications 2014; 28: 536-541 DOI: 10.1016/j.jdiacomp.2012.09.008.
• 29 Bogan KL, Brenner C. Nicotinic acid, nicotinamide, and nicotinamide riboside: A molecular evaluation of NAD+precursor vitamins in human nutrition. Annu Rev Nutr 2008; 28: 115-130 DOI: 10.1146/annurev.nutr.28.061807.155443.
• 30 Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference I, its Panel on Folate OBV, Choline. The National Academies Collection: Reports funded by National Institutes of Health. In: Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B(6), Folate, Vitamin B(12), Pantothenic Acid, Biotin, and Choline. Washington (DC): National Academies Press (US); 1998. DOI: 10.17226/6015
• 31 Hashimoto T, Perlot T, Rehman A. et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 2012; 487: 477-481 DOI: 10.1038/nature11228.
• 32 Fangmann D, Theismann EM, Türk K. et al. Targeted microbiome intervention by microencapsulated delayed-release niacin beneficially affects insulin sensitivity in humans. Diabetes Care 2018; 41: 398-405 DOI: 10.2337/dc17-1967.
• 33 Scheithauer TPM, Rampanelli E, Nieuwdorp M. et al. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front Immunol 2020; 11: 571731 DOI: 10.3389/fimmu.2020.571731.
• 34 Kaplon RE, Gano LB, Seals DR. Vascular endothelial function and oxidative stress are related to dietary niacin intake among healthy middle-aged and older adults. J Appl Physiol (1985) 2014; 116: 156-163 DOI: 10.1152/japplphysiol.00969.2013.
• 35 Jukarainen S, Heinonen S, Rämö JT. et al. Obesity is associated with low NAD(+)/SIRT pathway expression in adipose tissue of BMI-discordant monozygotic twins. J Clin Endocrinol Metab 2016; 101: 275-283 DOI: 10.1210/jc.2015-3095.